podcast

Medical Device Global Market Access

Pure Global

Navigate every market. Accelerate every launch. Medical Device Global Market Access by Pure Global is the audio briefing that turns the world’s most confusing regulatory pathways into clear, actionable roadmaps. If you’re a MedTech…

Nothing here is transcribed yet. Tick the episode you want: $1, ready in about two minutes.

$1 an episode · 10 for $5 · with credits: one per episode, any length · up to 25 at a time

Australia TGA Medical Device Fee Changes: What to Know for 2026 Audits 2026-10-22 · 5m
TGA AI Medical Scribe Regulation: When Clinical Software Becomes a Medical Device 2026-10-21 · 5m
Japan PMDA Generative AI Guidance: Key Review Points for Medical Device Manufacturers 2026-10-20 · 5m
Health Canada Medical Device Shortage Guidance: Exceptional Importation and Sale Updates 2026-10-19 · 5m
FDA Draft Guidance for Robotically Assisted Surgical Devices: Premarket Submission Insights 2026-10-18 · 6m
FDA GenAI Medical Device Regulation: Key Considerations Before the October 19, 2026 Comment Deadline 2026-10-17 · 5m
Singapore HSA-ACE Priority Track: Faster Market Access for Innovative Medical Devices 2026-10-16 · 5m
South Korea MFDS Proposes Faster Class II Medical Device Certification 2026-10-15 · 5m
Brazil ANVISA SaMD & AI Vigilance Rules: Mid-October 2026 Feedback Deadline 2026-10-14 · 4m
FDA 510(k) Exemption for Clinical Toxicology Devices: What IVD Makers Need to Know 2026-10-13 · 5m
India's Revised Materiovigilance (MvPI) Guidelines: Expanded Scope for Software, AI, and Cybersecurity 2026-10-12 · 5m
Australia TGA Proposes Greater Medical Device Transparency: What Sponsors Need to Know 2026-10-11 · 5m
UK MHRA AI Medical Device Rules: What the New Lifecycle Framework Means for Manufacturers 2026-10-10 · 5m
UK MHRA AI Medical Device Regulation: New Lifecycle Approach and AI Airlock Phase 3 2026-10-09 · 6m
China NMPA's Revised GMP: What Manufacturers Must Do by the November 2026 Deadline 2026-10-08 · 5m
Health Canada MDEL Amendments 2026: New Rules for Distributors and Importers 2026-10-07 · 5m
Indonesia Halal Certification: Class A Medical Device Deadline on October 17, 2026 2026-10-06 · 5m
UK MHRA Wireless CTG Safety Alert: Post-Market Actions for Manufacturers 2026-10-05 · 5m
Japan PMDA SaMD Guidance: 2026 Update and Submission Strategy 2026-10-04 · 5m
UK MHRA Patient Hoist Safety Alert: Actions for NatPSA/2026/005/MHRA by September 2026 2026-10-03 · 5m
SFDA Medical Device Advertising Compliance: Responding to New Enforcement Actions 2026-10-02 · 5m
TGA CDSS Exemption Changes: Preparing for the November 1, 2026 Deadline 2026-10-01 · 5m
Japan PMDA Generative AI: New Draft Criteria for Programmed Medical Devices 2026-09-30 · 6m
FDA Robotic Surgery Guidance: Key Changes for Premarket Submissions 2026-09-29 · 5m
EU EUDAMED SSCP/SSP Upload: MDCG 2026-4 Mandates Manufacturer Responsibility by October 2026 2026-09-28 · 5m
Brazil ANVISA Medical Device Vigilance: Public Call on SaMD and AI Rules 2026-09-27 · 5m
EU MDCG 2020-16 Rev 5: IVDR Classification for IVD Quality Control Materials 2026-09-26 · 6m
Brazil ANVISA High-Risk Device Registration: Navigating Public Consultation 1248 2026-09-25 · 5m
UK MHRA Health Bill Amendments: Future of Medical Device Licensing 2026-09-24 · 5m
FDA's New PMA Electronic Submission Template: Draft Guidance Explained 2026-09-23 · 5m
MFDS Korea Post-Market Study Exemption: Leveraging Overseas Data Under Notice 2026-63 2026-09-22 · 6m
Health Canada Exceptional Importation: Navigating the Updated Forms for Medical Device Shortages 2026-09-21 · 4m
China NMPA GMP Inspection Guidance: Preparing for the November 1, 2026 Deadline 2026-09-20 · 5m
FDA Radiology AI Software 510(k) Exemption: Final Order Clarifies Pathways for CADe/CADx Devices 2026-09-19 · 5m
China NMPA BCI Standard: New Rules for AI-Powered Medical Devices 2026-09-18 · 6m
China NMPA Policy on Localizing Imported Medical Device Production 2026-09-17 · 5m
Mexico COFEPRIS Authorized Third Parties: New 4-Year Validity and Operating Guidelines 2026-09-16 · 6m
SFDA AI Medical Software: Market Access in Saudi Arabia After First SaMD Approvals 2026-09-15 · 5m
Australia TGA CDSS Exemption 2026: What SaMD Manufacturers Need to Know 2026-09-14 · 5m
India CBIC Medical Device Import Checklist: New Customs Clearance Requirements 2026-09-13 · 5m
China NMPA's Dynamic Adjustment of Medical Device Classification: What Manufacturers Need to Know 2026-09-12 · 5m
SFDA Medical Device Advertising: Responding to Enforcement in Saudi Arabia 2026-09-11 · 5m
Australia TGA Device Classification Rules: Saline Flush Syringes Reclassified to Class IIa 2026-09-10 · 4m
China NMPA Approves LEQEMBI Autoinjector: A Signal for Drug-Device Combination Products 2026-09-09 · 5m
Brazil ANVISA High-Risk Device Registration: Public Consultation No. 1,248 Explained 2026-09-08 · 5m
Brazil ANVISA's New Notification Guidance: What Class I/II Medical Device and IVD Manufacturers Need to Know 2026-09-07 · 6m
Singapore HSA's New Registration Pathway for Special Access Route (SAR) Devices 2026-09-06 · 5m
UK MHRA Health Bill Amendments 2026: New Powers for Future Device Regulation 2026-09-05 · 4m
UK MHRA's New Licensing Powers: What the 2026 Health Bill Amendments Mean for Medical Device Manufacturers 2026-09-04 · 5m
UK MHRA Non-Compliant Devices: DSI/2026/007 and Supply Chain Risks 2026-09-03 · 5m
Australia TGA Consultation on Medical Device Information Sharing: What Sponsors Need to Know 2026-09-02 · 4m
Health Canada Special Access Program: New Application Process for Medical Devices 2026-09-01 · 6m
UK MHRA ResMed Astral Alert: Ventilator Safety Actions for NatPSA/2026/004/MHRA 2026-08-31 · 5m
China NMPA Medical Device Approval: Analyzing the August 12, 2026 Batch 2026-08-30 · 5m
Singapore HSA's New Medical Device Cybersecurity Guide (GL-10-R1): Key Principles and Actions 2026-08-29 · 5m
COFEPRIS Medical Device Sanitary Registry Viewer: What Manufacturers Need to Know 2026-08-28 · 5m
India CDSCO Amends Sterilization Rules: What Removing the Loan Licence Means for Medical Devices 2026-08-27 · 4m
EU Notified Body Shake-Up: What the NSAI and TÜV NORD Exits Mean for MDR Certification 2026-08-26 · 5m
Japan PMDA Workshop: A Guide to Medical Device Market Entry for U.S. Firms 2026-08-25 · 5m
UK MHRA Rectal Catheter Alert: Infant Safety and Post-Market Lessons 2026-08-24 · 5m
Brazil ANVISA Innovative Device Pilot Program 2026: A Guide for High-Risk MedTech 2026-08-23 · 5m
SFDA Biocompatibility Requirements: Preparing Medical Device Submissions for Saudi Arabia 2026-08-22 · 5m
FDA Discussion Paper on Generative AI in Medical Devices: Feedback Deadline and Key Considerations 2026-08-21 · 5m
FDA Proposed Rule on Class I Accessories: 2026 Changes for 510(k) Exemption 2026-08-20 · 5m
Saudi Arabia SFDA Medical Device Advertising Rules: MDS-REQ 8 Compliance for Manufacturers 2026-08-19 · 6m
CMS RAPID Coverage Pathway: Breakthrough Device Reimbursement Changes 2026-08-18 · 5m
Australia TGA Suspends Corpuls Defibrillators: What It Means for Post-Market Compliance 2026-08-17 · 5m
MHRA National Alert DSI/2026/007: Quarantining Devices Without UKCA or CE Marks 2026-08-16 · 6m
MHRA Non-Compliant Medical Devices: UK Quarantine Order and Supply Chain Lessons 2026-08-15 · 5m
FDA MDUFA VI Fees: Proposed Increases for Overseas Manufacturers 2026-08-14 · 5m
India's Draft Drugs, Medical Devices and Cosmetics Bill 2026: Key Changes for Manufacturers 2026-08-13 · 5m
Health Canada MDEL Modernization: Preparing for Phase 2 Changes by December 2026 2026-08-12 · 5m
EU AI Act and Medical Devices: New Compliance Deadline of August 2, 2028 2026-08-11 · 6m
China NMPA's 57 New Medical Device Guidelines: Immediate Impacts for Manufacturers 2026-08-10 · 4m
FDA Human Factors Guidance 2026: Navigating New eSTAR Requirements 2026-08-09 · 5m
ANVISA Chile ISP Cooperation: Preparing for Latin American Regulatory Convergence 2026-08-08 · 5m
FDA Human Factors Guidance 2026: What 510(k) and PMA Teams Need to Know 2026-08-07 · 5m
FDA Non-Device Software Functions: Public Input Deadline for 2026 Report 2026-08-06 · 5m
Mexico COFEPRIS Equivalence Pathway: New Guidance for Medical Device Registration 2026-08-05 · 5m
FDA Guidance on Hemodialysis Blood Tubing Sets: Key 510(k) Changes for July 23, 2026 2026-08-04 · 6m
UK MHRA AI Scribe Guidance: Clarifying Regulatory Status of AI Medical Scribes 2026-08-03 · 5m
SFDA Used Medical Device Resale: New Warning and Compliance Rules in Saudi Arabia 2026-08-02 · 5m
UK MHRA AI Scribe Regulation: New Guidance for Ambient Voice Technology 2026-08-01 · 5m
China NMPA 2026 Guidelines: Navigating 57 New Medical Device Rules 2026-07-31 · 5m
TGA AI Medical Device Regulation: Preparing for 2026-2027 Enforcement in Australia 2026-07-30 · 5m
Malaysia MDA Product Classification: Mandatory Online Submissions by August 2026 2026-07-29 · 5m
FDA's MDUFA VI Draft Commitment Letter: Key Proposals and the August 7 Comment Deadline 2026-07-28 · 5m
South Korea MFDS Proposal for Digital Medical Device Testing: What Manufacturers Need to Know 2026-07-27 · 4m
Saudi Arabia SFDA Medical Device Advertising: New MDS-REQ 8 Requirements for Manufacturers 2026-07-26 · 4m
India's 2026 CDSCO Guidance on Medical Device Software (MDSW): Key Compliance Steps 2026-07-25 · 5m
FDA eMDR System Enhancements 2026: A Guide for Medical Device Manufacturers 2026-07-24 · 6m
China NMPA Draft GMP Inspection Guideline: Risk-Based Audits and Critical Check Items 2026-07-23 · 5m
ANVISA Medical Device Regulation 2026: Brazil and Chile's Technical Exchange and Its Impact 2026-07-22 · 4m
ANVISA Technovigilance Changes in Brazil: What to Expect After the Public Consultation 2026-07-21 · 5m
South Korea Medical Device Act 2026: MFDS QMS and Distribution Rule Changes 2026-07-20 · 5m
Saudi Arabia SFDA Risk Communication Guidance: What MDS-G-029 Means for Manufacturers 2026-07-19 · 5m
Health Canada Ministerial Reliance Order: Faster Market Access for Medical Devices 2026-07-18 · 5m
UK MHRA Draft Medical Device Regulations 2026: Key Changes and Timeline 2026-07-17 · 5m
EU REP Symbol Transition: Compliance Guide for Medical Device Labeling by 2031 2026-07-16 · 5m
Saudi Arabia SFDA Medical Device Bundling: Key Changes in Guidance MDS-G-028 2026-07-15 · 5m
Australia TGA UDI Requirements: High-Risk Device Compliance by July 1, 2026 2026-07-14 · 5m
EU MDR Well-Established Technologies (WET) Exemption: New Rules for Class III and IIb Devices 2026-07-13 · 5m
China NMPA BCI Classification Guidance: A New Framework for Neurotech Devices 2026-07-12 · 6m
FDA MDUFA VI Reauthorization: What to Expect for FY 2028-2032 2026-07-11 · 6m
Brazil's New e-Notivisa System: ANVISA's Overhaul of Medical Device Adverse Event Reporting 2026-07-10 · 5m
Brazil ANVISA Regulatory Reliance: IN 290/2024 Changes for Class III & IV Devices 2026-07-09 · 5m
EU MDCG 2026-4: SSCP Upload to EUDAMED for Class III & Implantable Devices 2026-07-08 · 5m
China NMPA Innovative Device Approvals Accelerate: Market Access in 2026 2026-07-07 · 5m
Australia's TGA UDI System: Preparing for the July 1, 2026 High-Risk Device Deadline 2026-07-06 · 5m
Japan PMDA SaMD Guidance 2026: AI/ML, Cybersecurity, and Classification Changes 2026-07-05 · 5m
India CDSCO Proposes Faster Medical Device License Timelines 2026-07-04 · 5m
South Korea Medical Device Act 2026: MFDS QMS and Distribution Changes 2026-07-03 · 5m
FDA AI Medical Device Draft Guidance 2026: Lifecycle Management and Submission Requirements 2026-07-02 · 5m
Health Canada MDEL Modernization Phase 2: 2026 Changes for Importers and Distributors 2026-07-01 · 6m
Australia TGA Classification Rule 5.5: Reclassification Changes for Medical Devices 2026-06-30 · 5m
Switzerland's Swissdamed: Mandatory Device and IVD Registration by July 2026 2026-06-29 · 5m
UK MHRA International Reliance: Navigating the Draft 2026 Medical Device Regulations 2026-06-28 · 5m
Brazil ANVISA Regulatory Reliance: June 2024 Update to IN 290/2024 Streamlines Class III/IV Device Review 2026-06-27 · 5m
China NMPA Post-Market Vigilance 2026: New Rules for Foreign Manufacturers 2026-06-26 · 5m
Saudi SFDA's 2026 AI Medical App Approval: A Global First for Vital Signs Monitoring 2026-06-25 · 5m
UK MHRA MDSAP Membership: Streamlining Audits for UK, US, Canada, and More 2026-06-24 · 5m
Singapore HSA COVID-19 IVD Reclassification: Class C Requirements from 2026 2026-06-23 · 5m
India CDSCO Proposes New Medical Device Import Rules for Hospitals (2026) 2026-06-22 · 6m
Health Canada's 2026 Hyperbaric Chamber Warning: Compliance for Unlicensed Devices 2026-06-21 · 5m
Health Canada MDEL Regulations 2026: What Importers and Foreign Manufacturers Need to Know 2026-06-20 · 5m
FDA AI Software Classification 2026: Class II and PCCP Rules for Imaging Devices 2026-06-19 · 5m
Brazil ANVISA SaMD Regulation Update: Preparing for Changes to RDC 657/2022 2026-06-18 · 5m
Singapore HSA's 2026 Medical Device Grouping Guidance: Key Changes in GN-12-1-R3 2026-06-17 · 5m
Australia TGA UDI Deadline: Class III & IIb Device Compliance by July 1, 2026 2026-06-16 · 5m
Japan PMDA SaMD Guidance: Key Changes from the June 2026 Update 2026-06-15 · 5m
FDA AI Medical Device Guidance 2026: New Rules for Transparency and Lifecycle Management 2026-06-14 · 5m
FDA Payor Communications Guidance 2026: What Medical Device Manufacturers Need to Know 2026-06-13 · 5m
FDA 510(k) Exemption for Unclassified Devices: New June 2026 Guidance 2026-06-12 · 5m
EU AI Act & Medical Devices: Deadline Extended to 2028 for High-Risk Systems 2026-06-11 · 5m
FDA 510(k) Exemption Guidance 2026: Five New Product Codes Exempted 2026-06-10 · 5m
China NMPA's New Dynamic Medical Device Classification: What Manufacturers Need to Know 2026-06-09 · 5m
EU Notified Body Timelines: New MDR & IVDR Rules for Predictable CE Marking 2026-06-08 · 5m
UK MHRA Draft 2026 Medical Device Regulations: International Reliance and What's Next 2026-06-07 · 5m
Mexico's New Medical Device Labeling Standard: COFEPRIS NOM-137-SSA1-2025 Compliance by 2027 2026-06-06 · 5m
FDA's New Human Factors Guidance: Navigating Risk for 510(k) and PMA Submissions 2026-06-05 · 5m
The EUDAMED Countdown: Mandatory EU Device Registration Begins May 28, 2026 2026-06-04 · 3m
Winning the Heart: MedTech's Race for a Full Structural Heart Ecosystem by 2026 2026-04-10 · 3m
The 2026 Neurotechnology Leap: Navigating BCI Commercialization, Reimbursement, and FDA Hurdles 2026-04-09 · 3m
AI Scribes & Ambient Documentation: A 2026 Clinical Infrastructure Forecast 2026-04-08 · 3m
AI Chatbot Governance in MedTech: Balancing Safety and Speed in 2026 2026-04-07 · 4m
The 2026 Diagnostics Revolution: Value Creation in Molecular Testing, Oncology, and Personalized Medicine 2026-04-06 · 3m
Medicare's PAMA Problem: Will 2026 Reimbursement Cuts Crush US Diagnostics Innovation? 2026-04-05 · 3m
2026 MedTech M&A Forecast: Blockbuster Deals in Diagnostics & Structural Heart or Continued Caution? 2026-04-04 · 3m
2026 MedTech Forecast: Tariffs, Supply-Chain Nationalism, and Manufacturing Strategy 2026-04-03 · 3m
The Great EU MedTech Squeeze: Portfolio Pruning and Consolidation Under MDR/IVDR in 2026 2026-04-02 · 3m
FDA's 2026 MDUFA Impact: A Strategic Guide for Small MedTech Companies 2026-04-01 · 3m
The 2026 AI MedTech Challenge: Cracking the Reimbursement Code 2026-03-31 · 3m
Diabetes Tech in 2026: The Battle Between Closed-Loop Innovation and Regulatory Reality 2026-03-30 · 3m
Decentralized Diagnostics: Regulatory Pathways for AI-Powered Imaging in 2026 2026-03-29 · 4m
The 2026 Surgical Robotics Shake-Up: FDA Approvals, Specialization, and New Competition 2026-03-28 · 3m
FDA's New Cybersecurity Era: Why SBOMs and Secure Architecture are Non-Negotiable for MedTech by 2026 2026-03-27 · 3m
FDA's 2026 TEMPO Pilot: The Bridge to Reimbursement for Digital Health? 2026-03-26 · 3m
U.S. FDA vs. Wearables: The 2026 Regulatory Showdown for Digital Health 2026-03-25 · 4m
FDA's 2026 AI Device Scrutiny: Lifecycle Governance and Real-World Performance 2026-03-24 · 3m
Home-Use Device Recalls & Firmware Updates: Navigating the MedTech Logistical Nightmare 2026-03-15 · 3m
Securing the MedTech Supply Chain: Blockchain vs. 3D-Printed Counterfeits 2026-03-14 · 3m
Self-Healing Logistics: Automating Medical Device Supply Chains in a Volatile World 2026-03-13 · 3m
AI Diagnostic Bias: Navigating FDA and Global Regulations to Avoid Market Withdrawal 2026-03-12 · 4m
ASC Sales Strategy: Adapting MedTech for the 2026 Procedure Shift 2026-03-11 · 3m
MedTech's Subscription Shift: Surviving the Death of Hospital Capital Expenditures 2026-03-10 · 3m
USA's Breakthrough Device Dilemma: Closing the Medicare Reimbursement Gap 2026-03-09 · 3m
Beyond the AI Hype: The Human Validation Bottleneck in MedTech Submissions 2026-03-08 · 4m
Cybersecurity in MedTech: Surviving Digital Darkness and Meeting FDA & EU Demands 2026-03-07 · 4m
Beyond the Clinical Trial: Unlocking MedTech Market Access with Real-World Evidence 2026-03-06 · 3m
EU AI Act: Navigating High-Risk Classification & Dual MDR/IVDR Compliance for Medical Devices 2026-03-05 · 3m
FDA's QMSR Shift: Harmonizing US Quality Systems with ISO 13485 Before 2026 2026-03-04 · 3m
EU MDR Compliance: Surviving the Notified Body Capacity Shortage in Europe 2026-03-03 · 3m
Countdown to EUDAMED: Mastering the EU's May 2026 MedTech Deadline 2026-03-02 · 3m
Singapore HSA Fees: A Cost Breakdown for Class B, C, & D Medical Device Registration 2026-03-01 · 3m
Singapore MedTech Compliance: Mastering the SS 620 GDPMDS Standard for Device Distribution 2026-02-28 · 3m
Singapore MedTech Market: A Guide to HSA's Importer, Wholesaler & Manufacturer Licenses 2026-02-27 · 3m
Navigating Singapore's HSA: The Class A Medical Device Registration Exemption 2026-02-26 · 3m
Unlocking Singapore: Mastering the ASEAN CSDT for Medical Device Registration 2026-02-25 · 3m
Singapore HSA Fast-Track: Leveraging FDA, CE Mark & TGA Approvals for Device Registration 2026-02-24 · 3m
Singapore MedTech Compliance: Navigating HSA Registrant & Representative Roles 2026-02-23 · 3m
Singapore HSA Pathways: A Guide to Immediate, Expedited & Abridged MedTech Registration 2026-02-22 · 3m
Singapore HSA: A Guide to Medical Device Risk Classification (Class A-D) 2026-02-21 · 3m
Singapore Medical Device Registration: Navigating the HSA & Health Products Act 2026-02-20 · 3m
Navigating INVIMA: Colombian Rules for Medical Device Labeling, IFU, and Spanish Translation 2026-02-19 · 3m
Colombia's INVIMA Medical Device Registration: A Breakdown of Government Fees and Ongoing Costs 2026-02-18 · 3m
Colombia's INVIMA Registration: Is FDA or CE Mark Approval a Must? 2026-02-17 · 3m
Colombia INVIMA Medical Device Registration: Technical Files, CFS, and Apostille Requirements 2026-02-16 · 3m
Colombia's INVIMA Approval Timelines: Standard vs. Expedited Medical Device Pathways 2026-02-15 · 3m
Colombia's INVIMA Regulations: Legal Representative Duties for Medical Device Registration 2026-02-14 · 3m
Colombia's Medical Device Classification: Navigating INVIMA's Risk Rules for Class I to III Devices 2026-02-13 · 3m
Colombia's INVIMA: Medical Device Registration Pathways and Timelines 2026-02-12 · 3m
EU MDR & IVDR Readiness: Mastering Economic Operator and PRRC Roles 2026-02-11 · 3m
MedTech's Sustainability Dilemma: Reprocessing, Risk, and the Future of Single-Use Devices 2026-02-10 · 3m
Unlocking European Markets: Companion Diagnostics (CDx) Strategy Under IVDR 2026-02-09 · 3m
EU IVDR Clarity: Navigating IVD Performance Studies with MDCG 2025-5 2026-02-08 · 3m
Navigating EU IVDR: A Deep Dive into Performance Evaluation for High-Risk IVDs 2026-02-07 · 3m
EU Medical Device Cybersecurity: Navigating MDCG 2019-16 Under MDR & IVDR 2026-02-06 · 3m
EU AI Act & MDR/IVDR: Decoding the New Dual Compliance Roadmap for AI Medical Devices 2026-02-05 · 3m
EU SaMD Regulations: Mastering App Store Compliance and 'Making Available' Rules 2026-02-04 · 3m
EU Legacy Devices: Navigating the 'Significant Change' Maze Under MDR & IVDR 2026-02-03 · 3m
Beyond the Barcode: Mastering MedTech UDI for EUDAMED & Global Markets 2026-02-02 · 3m
EU MDR Vigilance & Trend Reporting: A Deep Dive into CAPA and FSCA Decisions 2026-02-01 · 4m
Beyond the Plan: Mastering PMS and PMCF Execution Under EU MDR 2026-01-31 · 3m
EU MDR Clinical Evidence: Mastering CERs, PMCF, and Equivalence Arguments 2026-01-30 · 3m
EU MDR & IVDR Certification: Navigating the Notified Body Capacity Crunch and Timeline Compression 2026-01-29 · 3m
EU MDR & IVDR Simplification: What the 2025 Proposal Means for MedTech 2026-01-28 · 3m
EU Supply Chain Alert: Navigating Medical Device Shortage Notifications Under Regulation 2024/1860 2026-01-27 · 3m
EU IVDR Extension: Key Conditions & Deadlines Under Regulation 2024/1860 2026-01-26 · 3m
The EUDAMED Clock is Ticking: Understanding the EU's Mandatory 2026 Deadlines 2026-01-25 · 3m
COFEPRIS Uncovered: Comparing Mexico's Device Classification to FDA and EU Rules 2026-01-24 · 3m
MFDS to COFEPRIS: Why Your Korean Medical Device Classification is Invalid in Mexico 2026-01-23 · 3m
Korean Devices in Mexico: Mastering COFEPRIS Classification and Grouping 2026-01-22 · 3m
COFEPRIS & MFDS: A New 30-Day Fast-Track for Korean MedTech in Mexico 2026-01-21 · 3m
Mexico's COFEPRIS Regulations: A Guide for Korean MedTech on Appointing a Mandatory Registration Holder (MRH) 2026-01-20 · 3m
Cracking COFEPRIS: Spanish Language Strategy for Korean MedTech in Mexico 2026-01-19 · 3m
Brazil & MERCOSUR: A Strategic Gateway for Korean MedTech 2026-01-18 · 3m
Brazil's SUS & ANVISA: A Guide for Korean MedTech 2026-01-17 · 3m
Korea to Brazil: Bridging the Cultural Divide in MedTech Business 2026-01-16 · 3m
Korea to Brazil: Navigating ANVISA's Extended Medical Device Registration Timelines 2026-01-15 · 3m
ANVISA's Gateway to Brazil: Why Korean MFDS Approval is Non-Negotiable 2026-01-14 · 3m
Brazil's INMETRO Certification: A Guide for Korean Electro-Medical Device Manufacturers 2026-01-13 · 3m
Cracking the Code: Brazil's Complex Import Taxes for Korean MedTech 2026-01-12 · 3m
Brazil's ANVISA: The Portuguese Language Barrier for Korean MedTech 2026-01-11 · 3m
Korean MedTech in Brazil: Navigating ANVISA's B-GMP Certification 2026-01-10 · 3m
Korean MedTech in Brazil: Unlocking ANVISA Approval with a Brazilian Registration Holder (BRH) 2026-01-09 · 3m
EU MDR Clinical Investigations: Navigating Deadlines and Data Requirements for European Market Access 2026-01-08 · 4m
Navigating COFEPRIS: A Guide to Dental Device Registration and Market Access in Mexico 2026-01-07 · 3m
Accessing Mexico's Dental Market: A Guide to COFEPRIS Regulatory Approval 2026-01-06 · 3m
COFEPRIS Approval: Your Strategy for the Mexican Dental Device Market 2026-01-05 · 3m
Navigating Mexico's IVD Market: COFEPRIS Compliance and the Distributor Gateway 2026-01-04 · 3m
Mexico's IVD Market: Mastering COFEPRIS & Distributor Strategy 2026-01-03 · 3m
Mexico's IVD Market Expansion: A Distributor Strategy with PIDSA 2026-01-02 · 3m
Medical Imaging & Radiology in Mexico: The Medical Prado Case Study 2026-01-01 · 3m
Partnering for Success: Navigating Mexico's Medical Imaging Sector 2025-12-31 · 3m
Mexico's Radiology Market: A Distributor's Role with Agfa, Philips, and IMADINE 2025-12-30 · 3m
Unlocking Mexico: A Strategic Guide to Orthopedic & Trauma Device Distribution 2025-12-29 · 3m
COFEPRIS Registration & Market Strategy for Orthopedic Devices in Mexico 2025-12-28 · 3m
Mexico's Orthopedic Implants Market: Navigating COFEPRIS Regulations & Trauma Sector Growth 2025-12-27 · 3m
Mexico Market Access: The Role of Specialized Distributors in Interventional Cardiology & Radiology 2025-12-26 · 3m
Accessing Mexico’s MedTech Scene: A Case Study in Interventional Cardiology and Radiology 2025-12-25 · 3m
Mexico's COFEPRIS Approval: Fast-Tracking Cardiology & Radiology Devices 2025-12-24 · 3m
Brazil's Dental Market: Unlocking Access with Key Distributors like Dental Speed 2025-12-23 · 3m
Brazil's Dental Market: Unlocking Access with Dental Cremer and Henry Schein 2025-12-22 · 3m
Brazil's Diagnostic Imaging Boom: Navigating Market Entry After ANVISA's 2024 Regulatory Shift 2025-12-21 · 3m
Siemens Healthineers: AI, CT, and Cardiology Imaging in Brazil 2025-12-20 · 3m
GE HealthCare's Brazil Strategy: Localizing Diagnostic Imaging Manufacturing 2025-12-19 · 3m
DePuy Synthes in Brazil: Navigating ANVISA's RDC 751/2022 for Orthopedic Devices 2025-12-18 · 4m
Zimmer Biomet in Brazil: A Blueprint for Orthopedic Device Market Access & ANVISA Compliance 2025-12-17 · 3m
Cracking the Brazilian Market: How Stryker Dominates Orthopedic Device Distribution 2025-12-16 · 3m
Unlocking the Brazilian MedTech Market: ANVISA's Reliance Route & High-Risk Cardiology Devices 2025-12-15 · 3m
Brazil Market Access: Boston Scientific's Cardiology Playbook 2025-12-14 · 3m
Brazil MedTech Market: A Medtronic Cardiology Case Study on Long-Term Success 2025-12-13 · 3m
Global MedTech Expansion: Key Strategies for Market Access in the US, EU, and Asia 2025-12-12 · 3m
McKesson's 2025 Spin-Off: A New Era for US Medical Device Distribution 2025-12-11 · 3m
Cardinal Health's GMPD: A Deep Dive into US Medical Distribution Strategy for 2025 2025-12-10 · 2m
The Medline Advantage: U.S. Market Dominance and a Landmark 2025 IPO 2025-12-09 · 3m
The US Hearing Aid Boom: Decoding the FDA's OTC Rule and 2025 Market Strategy 2025-12-08 · 3m
CPAP & APAP Technology: Navigating the Booming US Sleep Apnea Market 2025-12-07 · 3m
Pacemakers and ICDs in 2024-2025: Key Global Market and Technology Shifts 2025-12-06 · 3m
U.S. Joint Arthroplasty Trends: Robotics, Demographics, and the 2025 Implant Market 2025-12-05 · 3m
US Market Access: How CMS Reimbursement Fueled the CGM and Insulin Pump Boom 2025-12-04 · 3m
AI-Powered MedTech Regulation: Slashing Global Market Access Time by 75% 2025-12-03 · 3m
AI in MedTech Regulation: 70% Faster FDA Submissions & Japan Compliance Case Studies 2025-12-02 · 3m
Unlocking Global Markets: End-to-End Regulatory Services for MedTech and IVD Devices 2025-12-01 · 3m
Scaling MedTech: Tailored Regulatory Strategies for Startups, Scaleups, and Global Enterprises 2025-11-30 · 3m
Beyond Traditional Consulting: The Future of IVD and MedTech Market Access 2025-11-29 · 3m
Unlocking Global MedTech Markets: A Unified Strategy for Registration in the US, EU, and Asia 2025-11-28 · 3m
MedTech Market Entry: The True Cost of Free vs. Paid Regulatory Resources 2025-11-27 · 3m
Beyond the SaaS Hype: Real AI-Powered Global Market Access for MedTech 2025-11-26 · 3m
MedTech Expansion Strategy: Unlocking Underserved Global Markets in LATAM and APAC 2025-11-25 · 3m
AI in MedTech Regulatory Affairs: Scaling to 30+ Global Markets 2025-11-24 · 3m
Free AI Agents: The Future of Medical Device Registration in the US, EU, and Beyond 2025-11-23 · 3m
Colombia Medical Device Registration: Unpacking Decree 4725 of 2005 2025-11-22 · 3m
Mexico's Technovigilance: Mastering COFEPRIS NOM-240 for Post-Market Success 2025-11-21 · 3m
Mexico's New Medical Device Labeling Standard: A Deep Dive into NOM-137-SSA1-2024 2025-11-20 · 3m
Navigating NOM-241-SSA1-2021: Medical Device GMP Compliance in Mexico 2025-11-19 · 3m
Navigating COFEPRIS: A Deep Dive into Mexico's 'Reglamento de Insumos para la Salud' for Medical Devices 2025-11-18 · 3m
Mexico's COFEPRIS Framework: A Deep Dive into the Ley General de Salud for Medical Devices 2025-11-17 · 3m
Brazil GMP Certification: A Deep Dive into RDC 687/2022 for Class III/IV Devices 2025-11-16 · 3m
Navigating Brazil's ANVISA Technovigilance: A Deep Dive into RDC 67/2009 Reporting Timelines 2025-11-15 · 3m
Brazil's BGMP Overhaul: Navigating ANVISA RDC 665/2022 and MDSAP Compliance 2025-11-14 · 3m
Brazil's IVD Shake-up: ANVISA RDC 830/2023 and New Risk Classifications 2025-11-13 · 3m
ANVISA RDC 751/2022: A Manufacturer's Guide to Brazilian Device Registration 2025-11-12 · 4m
Singapore MedTech: How to Break Free from Distributor Lock-In 2025-11-11 · 4m
Unlocking Your MedTech in Vietnam: The Registration Holder Dilemma 2025-11-10 · 3m
Japan's D-MAH System: Regaining Control of Your Medical Device 2025-11-09 · 3m
Australia TGA Sponsor: How to Take Control of Your Medical Device Registration 2025-11-08 · 3m
Unlocking India: The Strategic Advantage of an Independent Authorized Agent 2025-11-07 · 3m
Regain Control: Transferring Your ANMAT Registration in Argentina 2025-11-06 · 3m
Unlock Chile: Why Your Distributor Shouldn't Own Your Medical Device Registration 2025-11-05 · 3m
Regain Control: Switching Your Medical Device Registration Holder in Peru 2025-11-04 · 3m
Mexico MedTech: Untangling Your COFEPRIS Registration Holder 2025-11-03 · 3m
Regain Control: Switching Your INVIMA Holder in Colombia 2025-11-02 · 3m
Brazil's MedTech Market: Escaping the Distributor Trap 2025-11-01 · 3m
UAE Regulatory Update: Gaining Control with an Independent LAR 2025-10-31 · 3m
SFDA Success: Regain Control by Switching Your Saudi Authorized Representative 2025-10-30 · 4m
Turkey's New Medical Device Rule: Why Your Distributor Is Now a Liability 2025-10-30 · 3m
Switzerland's CH-REP Rule: Is Your Distributor a Compliance Risk? 2025-10-29 · 4m
EU Medical Devices: Breaking Up with Your Distributor-AR in France 2025-10-28 · 3m
Switching Your German EC-REP: From Distributor to Independent Representative 2025-10-27 · 4m
Distributor as UKRP: The Hidden Risk to Your UK Market Access 2025-10-26 · 3m
Spain MedTech Compliance: Ditching Your Distributor for an Independent EC-REP 2025-10-25 · 4m
Unlocking Italy: The Distributor vs. Independent EU Rep Dilemma 2025-10-24 · 4m
Indonesia's MedTech Gatekeeper: Choosing Your Local Product License Holder 2025-10-23 · 3m
Unlocking the UAE MedTech Market: The Crucial Role of Your Local Representative 2025-10-22 · 5m
Navigating the SFDA: Your Guide to Saudi Authorized Representatives 2025-10-22 · 3m
Philippine Medical Device Registration: Why Your MAH Choice is Critical 2025-10-21 · 3m
Israel's Gatekeeper: Mastering the Role of the IRH for MedTech Success 2025-10-20 · 3m
Thailand's MedTech Gatekeeper: Navigating the Local Representative Role 2025-10-19 · 3m
Malaysia MedTech: Your Guide to Authorized Representatives & Registrants 2025-10-18 · 4m
Vietnam's MedTech Gatekeeper: The Crucial Role of the Registration Number Holder 2025-10-17 · 3m
Singapore's MedTech Gatekeeper: The Crucial Role of the Local Registrant 2025-10-16 · 3m
India's Medical Device Market: Your Guide to the Authorized Agent Requirement 2025-10-15 · 3m
China's NMPA Gatekeeper: The In-China Domestic Agent Explained 2025-10-14 · 3m
Unlocking the Japanese MedTech Market: The DMAH Strategy 2025-10-13 · 3m
The Australian Gatekeeper: Choosing Your TGA Medical Device Sponsor 2025-10-12 · 3m
New Zealand MedTech: The Crucial Role of the Local Sponsor 2025-10-11 · 3m
Canada's MedTech Entry Pass: MDL vs. MDEL Explained 2025-10-10 · 3m
Unlocking Switzerland: Your Guide to the Swiss Authorised Representative Requirement 2025-10-09 · 3m
Beyond the Mailbox: Your EU Rep's Critical MDR & IVDR Duties 2025-10-08 · 3m
Post-Brexit MedTech Compliance: The Crucial Role of the UK Responsible Person 2025-10-07 · 3m
Brazil's Regulatory Gatekeeper: Navigating the Brazil Registration Holder Requirement 2025-10-06 · 3m
FDA's Gatekeeper: A Guide to the U.S. Agent for Foreign MedTech Companies 2025-10-05 · 3m
The MedTech Partnership Playbook: A Blueprint for Mutual Growth 2025-10-04 · 3m
Expand Your Catalog: A Distributor's Guide to Profitable MedTech Partnerships 2025-10-03 · 3m
Supercharge Your MedTech Consultancy: Drive Client Success & New Revenue 2025-10-02 · 3m
De-Risking MedTech Investments: A VC's Guide to Regulatory Success 2025-10-01 · 3m
Regulatory Red Flags: Fixing Common Submission Gaps Before They Derail Your Device Approval 2025-09-30 · 3m
Your Blueprint for Global MedTech Compliance 2025-09-29 · 4m
Is Your MedTech Firm Ready for Europe? Avoiding Critical EU MDR Pitfalls 2025-09-28 · 4m
Regulatory Foresight: A Blueprint for Global MedTech Success 2025-09-27 · 4m
Local Reps, Global Reach: The Unseen Gatekeepers of MedTech Access 2025-09-26 · 4m
UAE MedTech Approval: Decoding the MOHAP Process 2025-09-25 · 3m
UAE MedTech Approval: Your MOHAP Dossier and Simplified Pathway Guide 2025-09-25 · 3m
The Gatekeeper: Unlocking the UAE MedTech Market with the Right Local Partner 2025-09-25 · 3m
UAE Regulatory Overhaul: Unpacking Federal Decree-Law 38 for MedTech 2025-09-24 · 3m
UAE MedTech Market Entry: A Guide to Timelines and Costs 2025-09-23 · 3m
Beyond the Sale: The Critical Role of MedTech Service and Logistics 2025-09-22 · 3m
Distributor Contracts: Your Performance Shield or a Risky Gamble? 2025-09-22 · 3m
U.S. Agent vs. Initial Importer: A Critical Choice for FDA Import Success 2025-09-21 · 3m
The Distributor Mismatch: Finding Your IVD's Champion in the U.S. Market 2025-09-20 · 3m
From Code to Cash: A Guide to U.S. Medical Device Reimbursement Rates 2025-09-19 · 3m
FDA Import Readiness: U.S. Agent vs. Initial Importer Explained 2025-09-18 · 3m
Beyond the Box: How Distributor Contracts Drive MedTech Reimbursement 2025-09-18 · 3m
MedTech's Last Mile: Ensuring Uptime with Superior Logistics 2025-09-18 · 3m
Beyond the Handshake: Structuring MedTech Distributor Contracts That Perform 2025-09-17 · 3m
Unlock the US IVD Market: Finding the Right Distributor Fit 2025-09-16 · 3m
Cracking the Code: IVD Reimbursement in Europe vs. The United States 2025-09-15 · 3m
Unlocking U.S. Medicare Coverage for Your IVD Test 2025-09-14 · 3m
IVD Pricing Power: The Post-Market Data Payers Demand 2025-09-13 · 3m
Securing Your Assay's CPT Code: A Guide to US Reimbursement and the CLFS 2025-09-12 · 4m
FDA Export Certificates: Navigating Apostille and Legalization Requirements 2025-09-11 · 3m
Unlocking Exports: FSC Documentation by Device Class 2025-09-10 · 3m
Your Product's Passport: Unlocking Global Sales with an FSC 2025-09-09 · 4m
Certificate of Free Sale: Who Is Eligible to Apply? 2025-09-08 · 3m
Navigating FDA Export Certificates: Timelines, Fees, and 2024 Updates 2025-09-08 · 3m
Unlocking the FDA 510(k) with Your Japanese PMDA Approval 2025-09-07 · 3m
From China to Brazil: Navigating ANVISA without NMPA Reliance 2025-09-06 · 4m
From Brazil to the US: Unpacking ANVISA and FDA 510(k) Pathways 2025-09-05 · 4m
From NMPA to CE Mark: Bridging the Regulatory Gap 2025-09-04 · 4m
From Tokyo to Brussels: Navigating the EU MDR After Japan Shonin 2025-09-03 · 3m
From NMPA to FDA: Leveraging China Approval for U.S. Market Entry 2025-09-03 · 5m
From Europe to Down Under: A Guide to TGA Approval with Your CE Mark 2025-09-02 · 3m
De Novo Submissions: Will Your CE Mark Data Pass FDA Scrutiny? 2025-09-01 · 4m
CE Mark to FDA 510(k): A Guide for MedTech Manufacturers 2025-08-31 · 3m
From Europe to Japan: Leveraging Your CE Mark for PMDA Approval 2025-08-31 · 4m
From Europe to Brazil: Bridging the CE Mark and ANVISA Gap 2025-08-30 · 3m
From MDR to NMPA: A Strategic Guide to China Market Entry 2025-08-29 · 3m
Unlocking the Canadian MedTech Market: Beyond the CE Mark 2025-08-28 · 4m
From CE to UKCA: Navigating the UK Medical Device Transition 2025-08-28 · 4m
Cracking the Code: Japan's PMD Act & QMS Requirements 2025-08-27 · 3m
China's Regulatory Overhaul: Your Guide to NMPA Order 739 2025-08-26 · 3m
Unlocking the Indian Market: A Guide to the 2017 and 2023 Device Rules 2025-08-25 · 3m
South Korea's Game-Changing 2025 Digital Medical Products Act 2025-08-24 · 3m
China's New Electrical Safety Standard: Navigating the GB 9706.1-2020 Transition 2025-08-24 · 6m
TGA Approval Down Under: A Guide to the 2002 Medical Device Regulations 2025-08-23 · 3m
Decoding NOM-241: Mexico's New GMP Framework for Medical Devices 2025-08-22 · 3m
Argentina's MedTech Gateway: Unpacking ANMAT's Key Registration Rules 2025-08-21 · 3m
Colombian Market Entry: Your Guide to Decree 4725 and INVIMA 2025-08-20 · 3m
Brazil's Regulatory Reset: A Guide to RDC 751/2022 2025-08-20 · 3m
Navigating Europe's MedTech Shift: A Guide to EU MDR Compliance 2025-08-19 · 4m
EU IVDR: Navigating New Deadlines and Stricter Rules 2025-08-18 · 3m
Navigating Canada's MedTech Market: A Guide to the CMDR 2025-08-17 · 3m
EU Clinical Trial Blueprint: Unpacking the MDCG 2024-3 Guidance 2025-08-16 · 3m
Navigating the UKCA Transition: Key Deadlines for Medical Device Manufacturers 2025-08-15 · 3m
Unlocking U.S. Clinical Studies: A Deep Dive into 21 CFR Part 812 2025-08-14 · 4m
Digital Compliance and Data Integrity: Mastering 21 CFR Part 11 2025-08-13 · 3m
FDA's New QMSR: Aligning with ISO 13485 and What It Means For You 2025-08-12 · 4m
Decoding 21 CFR Part 814: A Guide to the FDA's Premarket Approval Pathway 2025-08-11 · 4m
FDA's New Cyber Mandate: Navigating the 2023 Medical Device Security Rules 2025-08-10 · 3m
Post-Brexit MedTech: Your Guide from FDA to UKCA Marking 2025-08-09 · 3m
One Audit, Five Markets: Navigating the Medical Device Single Audit Program 2025-08-08 · 3m
Beyond FDA Approval: Unlocking the Saudi Arabian MedTech Market 2025-08-07 · 3m
Beyond FDA Clearance: Unlocking Japan's PMDA Approval 2025-08-06 · 3m
Beyond FDA: Securing Your Medical Device Import License in India 2025-08-05 · 3m
Cracking the Code: South Korea's MFDS for FDA-Approved Devices 2025-08-04 · 3m
The Human Factor: A Practical Guide to IEC 62366-1 Usability Engineering 2025-08-03 · 3m
Unlocking Global Markets with the New Health Software Security Standard 2025-08-02 · 3m
One Audit, Five Markets: Unlocking Global Access with MDSAP 2025-08-01 · 3m
From FDA Clearance to TGA Inclusion: Navigating the Australian Medical Device Market 2025-07-31 · 3m
From FDA PMA to Health Canada: A Guide to Licensing High-Risk Medical Devices 2025-07-30 · 4m
From FDA 510(k) to EU CE Mark: Bridging the Regulatory Gap 2025-07-29 · 4m
Leveraging Your FDA De Novo for Brazilian Market Access 2025-07-28 · 4m
Beyond FDA Clearance: A Guide to China's NMPA Medical Device Registration 2025-07-27 · 3m
Beyond the Lab: Mastering Clinical Trials with ISO 14155:2020 2025-07-26 · 4m
Navigating the New Rules of Medical Device Risk: ISO 14971:2019 Explained 2025-07-25 · 3m
From EC REP to EU REP: Decoding Critical Medical Device Symbol Changes 2025-07-24 · 3m
Unpacking IEC 60601-1 Edition 3.2: The New Standard for Electrical Safety 2025-07-23 · 4m
The Golden Key: How ISO 13485 Unlocks Global MedTech Markets 2025-07-22 · 4m
Intuitive's Newest Robot: A Surgeon's Sense of Touch 2025-07-21 · 3m
From Lab to Life: The Rise of Bioactive 3D-Printed Spinal Implants 2025-07-20 · 3m
The Remote Revolution: How At-Home Devices Are Solving the Physical Therapy Crisis 2025-07-19 · 3m
From Niche to Mainstream: The AI Revolution in Wearable Health Tech 2025-07-19 · 3m
AI and the Heart: How 3D Modeling is Transforming Cardiac Diagnosis 2025-07-18 · 3m
KIMES 2025: Your Gateway to South Korea's High-Tech Medical Device Market 2025-07-17 · 3m
Guangzhou 2024: Inside China's 5G Smart Hospital Revolution 2025-07-16 · 3m
Inside Riyadh's 2024 Global Health Exhibition: Your Gateway to Saudi MedTech 2025-07-15 · 2m
Your Gateway to Japan's Healthcare Market: Navigating MEDICAL JAPAN 2025 2025-07-14 · 3m
Accessing Latin America: Key Insights from Hospitalar 2024 2025-07-14 · 3m
Arab Health 2025: Your Strategic Gateway to the MENA MedTech Market 2025-07-13 · 3m
Decoding CMEF 2025: Your Gateway to China's MedTech Boom 2025-07-12 · 3m
One Audit, Six Markets? MDSAP vs. ISO 13485 in Southeast Asia 2025-07-11 · 4m
Unlocking Global Opportunities at MEDICA 2024 2025-07-10 · 3m
The Titans of MedTech: A Guide to the World's 3 Largest Industry Trade Shows 2025-07-09 · 3m
Unlocking the Malaysian Medical Device Market: A 2024 Regulatory Guide 2025-07-08 · 3m
Brazil's New MedTech Timeline: Understanding ANVISA Fees and Review Cycles Under RDC 751/2022 2025-07-07 · 4m
Malaysia MedTech: The Risks and Rewards of Self-Licensing 2025-07-06 · 3m
Cracking COFEPRIS: The Critical Stages After Your Mexican Device Submission 2025-07-05 · 3m
Beyond the Hospital: The Rise of Long-Term Care Devices 2025-07-04 · 3m
Beyond the Great Wall: Unlocking China's Medical Device Market in 2025 2025-07-03 · 4m
The African MedTech Market: Your 2025 Growth and Opportunity Briefing 2025-07-02 · 4m
The Asian MedTech Frontier: Seizing Opportunity in a High-Growth Market 2025-07-01 · 3m
MedTech Compliance 101: Your Guide to Entering Global Markets 2025-06-30 · 3m
Unlocking Market Access: A Guide to Clinical Evaluation & Investigations 2025-06-29 · 4m
From Dossier to Dominance: Mastering Pre-Market Submissions 2025-06-28 · 4m
FDA's New QMSR: A Practical Guide to Harmonization with ISO 13485 2025-06-27 · 4m
FDA vs. EU: Decoding Medical Device Risk and Classification Pathways 2025-06-26 · 3m
The Gatekeepers of Global MedTech: Decoding the FDA, EMA, and NMPA 2025-06-25 · 3m
From Stressed to Prepared: A Guide to Acing MedTech Audits 2025-06-24 · 3m
South Asia's MedTech Surge: A Guide to Market Trends & Opportunities 2025-06-23 · 3m
Unlocking Indonesia: Your MedTech Entry Strategy 2025-06-22 · 3m
U.S. MedTech Marketing: Navigating FDA & FTC Rules 2025-06-21 · 4m
Unlocking Markets: Navigating Medical Device Certifications 2025-06-20 · 6m
EU Market Entry: Mastering CE Marking for Medical Devices 2025-06-19 · 5m
Decoding FDA Medical Device Pathways 2025-06-18 · 3m
Decoding MedTech Regulations: QMSR, ISO 13485 & Global Strategy 2025-06-17 · 4m
Wearable Health: Revolutionizing Patient Care and Monitoring 2025-06-16 · 4m
2024-2025 MedTech Frontier: Devices Changing Patient Care 2025-06-15 · 5m
Protect & Prosper: Insurance Essentials for US MedTech 2025-06-14 · 3m
Navigating US Health Data Privacy: Is Your Device HIPAA-Ready? 2025-06-13 · 3m
ISO 13485 Explained: Your Key to MedTech Compliance and Trust 2025-06-12 · 4m
Unlock Global MedTech Markets: Finding Your Ideal Distributors 2025-06-11 · 5m
The Multi-Billion Dollar Diagnosis: Unpacking MedTech's Top Revenue Generator 2025-06-10 · 4m
Beyond EU Bottlenecks: MedTech's New Global Market Hotspots 2025-06-09 · 4m
MedTech Goes Global: Top 3 Expansion Strategies 2025-06-08 · 3m
CE Marking: The Golden Key for Global MedTech Entry 2025-06-07 · 5m
Decoding High-Risk Medical Device Classifications Worldwide 2025-06-06 · 3m
2025 MedTech Fast Track: FDA Breakthroughs & CMS Coverage Acceleration 2025-06-05 · 6m
Unlocking Global Markets: SaMD, AI, and Regulatory Fast-Tracks 2025-06-04 · 5m
China's 2025 MedTech Surge: NMPA's New Fast-Track for Innovative Devices 2025-06-03 · 5m
Saudi MedTech Breakthrough: Understanding the SFDA's MDS-G002 Pathway 2025-06-02 · 4m
Brazil's RDC 751/2022: Your 2025 MedTech Compliance Guide 2025-06-01 · 3m
FDA's Landmark QMSR Rule: ISO 13485 Harmonization for 2026 2025-05-31 · 4m
EU MDR's New Timetable: Are You Ready for 2025, 2027, and 2028? 2025-05-30 · 5m
EU IVDR: Strengthening Your MedTech Supply Chain Controls 2025-05-29 · 5m
Unlocking Worldwide IVD Access with Europe's IVDR 2025-05-28 · 4m
Leveraging Real-World Data: MHRA's Blueprint for Clinical Trials 2025-05-27 · 5m
Navigating MHRA's 2025 Real-World Data Guidance for UK Clinical Trials 2025-05-26 · 4m
Wireless MedTech: Navigating Global RF Compliance 2025-05-25 · 5m
Brazil's MedTech Pulse: Fresh Registration Insights for 2025 Q2 2025-05-23 · 5m
No episodes match. Older episodes may not be listed; email contact@podmenti.com for deep archives.

Medical Device Global Market Access

Ready in about two minutes.

We value your privacy